Lobbying client

RARE DISEASE THERAPEUTICS

Small bio-pharmaceutical company involved in orphan drug development

Filings
6
Filed by
1
Reported in-house
—
Reported by firms
$25,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2013

Filings

6 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2013
HPS GROUP, LLC — reported
1st Quarter - Report
1st Quarter 2013
HPS GROUP, LLC $10,000 reported
1st Quarter - Reportreplaced
1st Quarter 2013
HPS GROUP, LLC $10,000 reported
Mid-Year Amendment
Mid-Year 2007
HPS GROUP, LLC $15,000 reported
Year-End Termination
Year-End 2007
HPS GROUP, LLC — reported
Registration
Mid-Year 2007
HPS GROUP, LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
HPS GROUP, LLC 4 $25,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 5

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2900 110th 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.